!!Research output per year
!!Research output per year
Persoonlijk profiel
Expertise gerelateerd aan duurzame ontwikkelingsdoelstellingen van de VN
In 2015 stemden de VN-lidstaten in met 17 wereldwijde duurzame ontwikkelingsdoelstellingen (Sustainable Development Goals, SDG's) om armoede te beëindigen, de planeet te beschermen en voor iedereen welvaart te garanderen. Het werk van deze persoon draagt bij aan de volgende duurzame ontwikkelingsdoelstelling(en):
-
SDG 3 – Goede gezondheid en welzijn -
SDG 5 – Gendergelijkheid -
SDG 9 – Industrie, innovatie en infrastructuur -
SDG 10 – Minder ongelijkheid -
SDG 17 Partnerschap om de doelen te bereiken
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Dick de Zeeuw actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression
CKD-EPI Clinical Trials Consortium, Greene, T., Collier, W., Haaland, B., Zhang, C., Badve, S. V., Caravaca-Fontán, F., Del Vecchio, L., Floege, J., Hannedouche, T., Imai, E., Jafar, T. H., Lewis, J. B., Li, P. K. T., Locatelli, F., Maes, B. D., Neuen, B., Perrone, R. D., Schena, F. P. & Toto, R. & 5 anderen, , mei-2025, In: Clinical Journal of the American Society of Nephrology. 20, 5, blz. 632-641 10 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand3 Citaten (Scopus)86 Downloads (Pure) -
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial
Bornstein, S. R., de Zeeuw, D., Heerspink, H. J. L., Schulze, F., Cronin, L., Wenz, A., Tuttle, K. R., Hadjadj, S. & Rossing, P., jun-2024, In: Diabetes, Obesity and Metabolism. 26, 6, blz. 2128-2138 11 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand29 Citaten (Scopus)137 Downloads (Pure) -
Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease A Systematic Review and Retrospective Individual Participant–Level Meta-analysis of Clinical Trials
Ku, E., Inker, L. A., Tighiouart, H., McCulloch, C. E., Adingwupu, O. M., Greene, T., Estacio, R. O., Woodward, M., de Zeeuw, D., Lewis, J. B., Hannedouche, T., Jafar, T. H., Imai, E., Remuzzi, G., Heerspink, H. J. L., Hou, F. F., Toto, R. D., Li, P. K. & Sarnak, M. J., 2-jul-2024, In: Annals of Internal Medicine. 177, 7, blz. 953-963 12 blz.Onderzoeksoutput › peer review
Open AccessBestand40 Citaten (Scopus)161 Downloads (Pure) -
A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope
CANPIONE Study Investigators, Miyamoto, S., Heerspink, H. J. L., de Zeeuw, D., Sakamoto, K., Yoshida, M., Toyoda, M., Suzuki, D., Hatanaka, T., Nakamura, T., Kamei, S., Murao, S., Hida, K., Ando, S., Akai, H., Takahashi, Y., Kitada, M., Sugano, H., Nunoue, T. & Nakamura, A. & 8 anderen, , nov-2024, In: Kidney International. 106, 5, blz. 972-984 13 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand11 Citaten (Scopus)399 Downloads (Pure) -
Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes
Ku, E., Tighiouart, H., Mcculloch, C. E., Inker, L. A., Adingwupu, O. M., Greene, T., Estacio, R. O., Woodward, M., De Zeeuw, D., Lewis, J. B., Hannedouche, T., Hou, F. F., Jafar, T. H., Imai, E., Remuzzi, G., Heerspink, H. J. L., Toto, R. D. & Sarnak, M. J., okt-2024, In: Journal of the American Society of Nephrology. 35, 10, blz. 1402-1411 10 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand19 Citaten (Scopus)154 Downloads (Pure)
Datasets
-
Supplementary Material for: Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy
Yamout, H. (Creator), Perkovic, V. (Creator), Davies, M. (Creator), Woo, V. (Creator), De Zeeuw, D. (Creator), Mayer, C. (Creator), Vijapurkar, U. (Creator), Kline, I. (Creator), Usiskin, K. (Creator), Meininger, G. (Creator) & Bakris, G. (Contributor), Karger Publishers, 17-jul.-2014
DOI: 10.6084/m9.figshare.5126725, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Efficacy_and_Safety_of_Canagliflozin_in_Patients_with_Type_2_Diabetes_and_Stage_3_Nephropathy/5126725
Dataset
-
Additional file 2 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Dutius Andersson, A.-M. (Contributor), Garcia Hernandez, A. (Contributor), Tobin, K. (Contributor), Ball, C. (Contributor), Saunavaara, V. (Contributor), Teh, I. (Contributor), Banks, R. E. (Contributor), Sharma, K. (Contributor), Lienczewski, C. (Contributor), Koivuviita, N. (Contributor), Metsärinne, K. (Contributor), De Zeeuw, D. (Contributor), Karihaloo, A. (Contributor), Mansfield, M. (Contributor), Lambers Heerspink, H. (Contributor), Maziarz, M. (Contributor), Gesualdo, L. (Contributor), Pontrelli, P. (Contributor), Bailey, J. (Contributor), Papale, M. (Contributor), Nuutila, P. (Contributor), Gomez, M. F. (Contributor), Ibberson, M. (Contributor), Gooding, K. M. (Contributor), Sourbron, S. (Contributor), Shelley, D. (Contributor), Grenier, N. (Contributor), Shore, A. C. (Contributor), Zetterqvist, A. (Contributor), Welberry Smith, M. (Contributor), Gilchrist, M. (Contributor), Kretzler, M. (Contributor), Gilmour, P. S. (Contributor), Puppala, S. (Contributor) & Andress, D. (Contributor), University of Groningen, 29-jun.-2020
DOI: 10.6084/m9.figshare.12586628.v1
Dataset
-
Supplementary Material for: A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) – Study Design and Baseline Characteristics
Eder, S. (Contributor), Leierer, J. (Contributor), Kerschbaum, J. (Contributor), Rosivall, L. (Contributor), Wiecek, A. (Contributor), De Zeeuw, D. (Contributor), Mark, P. B. (Contributor), Heinze, G. (Contributor), Rossing, P. (Contributor), Lambers Heerspink, H. (Contributor) & Mayer, G. (Contributor), University of Groningen, 21-feb.-2018
DOI: 10.6084/m9.figshare.5909164.v1
Dataset
-
Supplementary Material for: A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) – Study Design and Baseline Characteristics
Eder, S. (Creator), Leierer, J. (Creator), Kerschbaum, J. (Creator), Rosivall, L. (Creator), Wiecek, A. (Creator), De Zeeuw, D. (Creator), Mark, P. B. (Creator), Heinze, G. (Creator), Rossing, P. (Creator), Lambers Heerspink, H. (Creator) & Mayer, G. (Creator), figshare, 21-feb.-2018
DOI: 10.6084/m9.figshare.5909164, https://figshare.com/articles/Supplementary_Material_for_A_Prospective_Cohort_Study_in_Patients_with_Type_2_Diabetes_Mellitus_for_Validation_of_Biomarkers_PROVALID_Study_Design_and_Baseline_Characteristics/5909164
Dataset
-
Supplementary Material for: The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Jardine, M. J. (Creator), Mahaffey, K. W. (Creator), Neal, B. (Creator), Agarwal, R. (Creator), Bakris, G. L. (Creator), Brenner, B. M. (Creator), Bull, S. (Creator), Cannon, C. P. (Creator), Charytan, D. M. (Creator), De Zeeuw, D. (Creator), Edwards, R. (Creator), Greene, T. (Creator), Lambers Heerspink, H. (Contributor), Levin, A. (Creator), Pollock, C. (Creator), Wheeler, D. C. (Creator), Xie, J. (Creator), Zhang, H. (Creator), Zinman, B. (Creator), Desai, M. (Creator) & Perkovic, V. (Creator), Karger Publishers, 13-dec.-2017
DOI: 10.6084/m9.figshare.5696959, https://karger.figshare.com/articles/Supplementary_Material_for_The_Canagliflozin_and_Renal_Endpoints_in_Diabetes_with_Established_Nephropathy_Clinical_Evaluation_CREDENCE_Study_Rationale_Design_and_Baseline_Characteristics/5696959
Dataset
Knipsels
-
‘Drug rediscovery vraagt bevlogen onderzoekers met creatieve invallen’
15/04/2026
1 Mediabijdrage
Pers / media: Expert Comment › Popular